CompareMarketResearchRequest a sample
Home / Healthcare / Single Use Bioreactor

Healthcare · Market report

Single Use Bioreactor Market Size, Share and Forecast 2026-2036

The global single use bioreactor market is worth USD 6.2 bn in 2026 and is forecast to reach USD 19.1 bn by 2036, growing at a 12.0% CAGR. United States is the largest country market and Bioreactor bags and assemblies is the largest by product segment.

USD 6.2 bnMarket size 2026
USD 19.1 bnForecast 2036
12.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global single use bioreactor market is worth USD 6.2 bn in 2026 and is forecast to reach USD 19.1 bn by 2036, growing at a 12.0% CAGR. United States is the largest country market and Bioreactor bags and assemblies is the largest by product segment.

ScopeSingle-use bioreactor systems and disposable bags with sensors and accessories used to culture cells for biologics, vaccines and cell and gene therapy.
IndustryHealthcare
Value 2025USD 5.5 bn
Value 2026USD 6.2 bn
Value 2036USD 19.1 bn
CAGR 2026-203612.0%
Volume 20261,672 thousand units
Volume 20364,939 thousand units
Average price 2026USD 3,685 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Single Use Bioreactor market size and forecast, 2026-2036

Exhibit 1The global single use bioreactor market is forecast to grow from USD 6.2 bn in 2026 to USD 19.1 bn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 12.0%
Single Use Bioreactor market value, 2025 to 2036Market value by year. 2025: USD 5.5 bn; 2026: USD 6.2 bn; 2027: USD 6.9 bn; 2028: USD 7.7 bn; 2029: USD 8.7 bn; 2030: USD 9.7 bn; 2031: USD 10.9 bn; 2032: USD 12.2 bn; 2033: USD 13.6 bn; 2034: USD 15.3 bn; 2035: USD 17.1 bn; 2036: USD 19.1 bn. Compound annual growth rate 2026 to 2036: 12.0%.20256.2 bn202610.9 bn203119.1 bn203612.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 6.2 bn
2027USD 6.9 bn
2028USD 7.7 bn
2029USD 8.7 bn
2030USD 9.7 bn
2031USD 10.9 bn
2032USD 12.2 bn
2033USD 13.6 bn
2034USD 15.3 bn
2035USD 17.1 bn
2036USD 19.1 bn

Single Use Bioreactor market segmentation

By product

Exhibit 2Bioreactor bags and assemblies is the largest segment by product, with 58.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Single Use Bioreactor market share by product, 2026Share of 2026 revenue by product. Bioreactor bags and assemblies: 58.0%; Bioreactor systems: 28.0%; Sensors and accessories: 14.0%.Bioreactor bags and assemblies58.0%Bioreactor systems28.0%Sensors and accessories14.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Bioreactor bags and assemblies58.0%58.6%USD 3.6 bn12.1%
Bioreactor systems28.0%25.9%USD 1.7 bn11.1%
Sensors and accessories14.0%15.5%USD 862 mn13.1%

By scale

Exhibit 3Commercial manufacturing adds the most revenue by scale, growing from USD 2.7 bn in 2026 to USD 8.5 bn by 2036Estimated revenue in USD by scale, 2026 and 2036 forecast
Single Use Bioreactor market by scale, 2026 and 2036Revenue by scale in 2026 and 2036. Commercial manufacturing: USD 2.7 bn in 2026, USD 8.5 bn in 2036, change +213%; Clinical manufacturing: USD 1.8 bn in 2026, USD 6.1 bn in 2036, change +228%; Process development: USD 1.6 bn in 2026, USD 4.6 bn in 2036, change +186%.20262036 forecastChangeCommercial manufacturing+213%2.7 bn8.5 bnClinical manufacturing+228%1.8 bn6.1 bnProcess development+186%1.6 bn4.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Process development26.0%24.0%USD 1.6 bn11.1%
Clinical manufacturing30.0%31.6%USD 1.8 bn12.6%
Commercial manufacturing44.0%44.4%USD 2.7 bn12.1%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biopharmaceutical companies62.0%60.1%USD 3.8 bn11.7%
Contract manufacturers26.0%28.8%USD 1.6 bn13.2%
Academic and research12.0%11.1%USD 739 mn11.2%

By working volume

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Bench scale28.0%24.0%USD 1.7 bn10.3%
Pilot scale30.0%28.0%USD 1.8 bn11.2%
Production scale30.0%32.0%USD 1.8 bn12.7%
Large scale12.0%16.0%USD 739 mn15.3%

By material

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Polyethylene62.0%60.0%USD 3.8 bn11.6%
EVA multilayer22.0%20.0%USD 1.4 bn10.9%
Others16.0%20.0%USD 986 mn14.5%

Top 25 countries for single use bioreactor by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.0% of 2026 revenue and the 25 countries below together hold 96.3%.

Exhibit 4United States is the largest country market at USD 2.3 bn in 2026, and the three largest countries hold 56.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Single Use Bioreactor market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 2.3 bn, 38.0%; Germany: USD 554 mn, 9.0%; China: USD 554 mn, 9.0%; Switzerland: USD 370 mn, 6.0%; Ireland: USD 308 mn, 5.0%; United Kingdom: USD 308 mn, 5.0%; Japan: USD 246 mn, 4.0%; South Korea: USD 246 mn, 4.0%; Singapore: USD 246 mn, 4.0%; France: USD 185 mn, 3.0%.United States2.3 bn 38.0%Germany554 mn 9.0%China554 mn 9.0%Switzerland370 mn 6.0%Ireland308 mn 5.0%United Kingdom308 mn 5.0%Japan246 mn 4.0%South Korea246 mn 4.0%Singapore246 mn 4.0%France185 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 2.3 bn38.0%USD 6.9 bn11.5%
2GermanyUSD 554 mn9.0%USD 1.6 bn11.0%
3ChinaUSD 554 mn9.0%USD 2.3 bn15.5%
4SwitzerlandUSD 370 mn6.0%USD 1.1 bn11.4%
5IrelandUSD 308 mn5.0%USD 918 mn11.5%
6United KingdomUSD 308 mn5.0%USD 918 mn11.5%
7JapanUSD 246 mn4.0%USD 670 mn10.5%
8South KoreaUSD 246 mn4.0%USD 880 mn13.6%
9SingaporeUSD 246 mn4.0%USD 804 mn12.6%
10FranceUSD 185 mn3.0%USD 555 mn11.6%
11CanadaUSD 128 mn2.1%USD 381 mn11.5%
12SpainUSD 76 mn1.2%USD 226 mn11.4%
13ItalyUSD 56 mn0.9%USD 166 mn11.5%
14NetherlandsUSD 46 mn0.7%USD 134 mn11.4%
15BelgiumUSD 38 mn0.6%USD 115 mn11.6%
16DenmarkUSD 33 mn0.5%USD 99 mn11.6%
17SwedenUSD 30 mn0.5%USD 88 mn11.5%
18IndiaUSD 27 mn0.4%USD 113 mn15.3%
19TaiwanUSD 25 mn0.4%USD 73 mn11.4%
20AustraliaUSD 23 mn0.4%USD 67 mn11.4%
21IsraelUSD 21 mn0.3%USD 90 mn15.7%
22AustriaUSD 20 mn0.3%USD 59 mn11.6%
23BrazilUSD 18 mn0.3%USD 78 mn15.6%
24MexicoUSD 18 mn0.3%USD 75 mn15.4%
25ThailandUSD 17 mn0.3%USD 71 mn15.6%
Rest of worldUSD 225 mn3.7%USD 614 mn10.5%
Exhibit 5United States and China account for 49% of the USD 13.0 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Single Use Bioreactor market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 6.2 bn. United States: +USD 4.6 bn; China: +USD 1.8 bn; Germany: +USD 1.0 bn; Switzerland: +USD 721 mn; South Korea: +USD 634 mn; 20 other countries: +USD 3.8 bn; Rest of world: +USD 389 mn. Market value 2036: USD 19.1 bn.Market value 20266.2 bnUnited States+4.6 bnChina+1.8 bnGermany+1.0 bnSwitzerland+721 mnSouth Korea+634 mn20 other countries+3.8 bnRest of world+389 mnMarket value 203619.1 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Sartorius
  • Thermo Fisher Scientific
  • Cytiva
  • Merck KGaA
  • Eppendorf
  • Pall Corporation

Group 2: Regional and specialist players

  • Corning
  • Getinge
  • PBS Biotech
  • Applikon
  • ABEC
  • Kuhner
  • Infors HT
  • Esco Lifesciences

Group 3: Emerging and niche players

  • Distek
  • Cellexus
  • Solida Biotech
  • Cesco Bioengineering
  • Bailun Biotechnology

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the single use bioreactor market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 12.0% is calculated from the resulting values.

The market is divided by product, by scale, by end user, by working volume, by material. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the single use bioreactor market?

The global single use bioreactor market is estimated at USD 5.5 bn in 2025 and USD 6.2 bn in 2026.

How fast will the single use bioreactor market grow?

It is forecast to reach USD 19.1 bn by 2036, a compound annual growth rate of 12.0% from 2026, an increase of USD 13.0 bn.

Which country is the largest market for single use bioreactor?

United States is the largest market by revenue at USD 2.3 bn in 2026, 38.0% of the global total. The three largest countries together hold 56.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 15.5% a year from 2026 to 2036.

Which single use bioreactor segment is largest?

In the by product split, Bioreactor bags and assemblies is the largest segment with 58.0% of 2026 revenue.

Who are the leading single use bioreactor companies?

Global leaders include Sartorius, Thermo Fisher Scientific, Cytiva, Merck KGaA.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Shelf-Stable Clinical Meal Small Molecule Drugs →

All Healthcare markets →

Request a sample